EDIUNET Free equity investment tool of Japanese companies

Companies Cart
@
Credit Rating Analysis
Annual
First quarter
Second quarter
Third quarter
Sponsored Link
Related Company
@ HOLON
@ Noritsu Koki
@ フクダ電子
@ A-One Seimitsu
@ オリンパス
@ TOKYO KEIKI
@ Techno Medica Co., Ltd.
@ ミツトヨ
@ Shimadzu
@ asahi intecc
@ Citizen Holdings
@ 大和製衡
@ DAIKEN MEDICAL
@ CHINO
@ メディキット
EDIUNET Related Ranking
EDIUNET
EDIUNET Credit Rating
EDIUNET Industry Avg
EDIUNET Prefectures
Yuho! Industry
EDIUNET Rating News
Prev « 2024-04 » Next
Mon Tue Wed Thu Fri Sat Sun
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
-
14
-
15
-
16
-
17
-
18
-
19
-
20
-
21
-
22
-
23
-
24
-
25
-
26
-
27
-
28
-
29
-
30
-
[Update list]
1/28 Retail Trade (CAWACHI:A etc...
1/27 Banks (The Awa Bank:BBB→A)
1/23 Chemicals (Milbon:AA→AAA)
1/21 Glass & Ceramics Products (..
1/21 Machinery (TSUDAKOMA:C)
1/21 Other Services (Netindex.:CC)
1/20 Other Products (Kurogane Kos..
1/20 Wholesale Trade (リーバイ・..
1/20 Other Services (川崎地質:BB→..
1/17 Chemicals (Kawaguchi Chemica..
 RSS
 Company RSS
 Daily RSS
Sponsored Link
Recently Download Chart
Yushiro Chemical Indutry
graph
Renesas Electronics
graph
ROHM
graph
NIPPON COKE & ENGINEERING
graph
NITCHITSU 
graph

Credit Rating Analysis: DAIKEN MEDICAL (Annual )

The details of credit rating (bankruptcy risk) can be checked. A credit rating in nine stages (AAA-C).

【Analysis Menu】 @Outline @Statement @Rating @Indicator @Download

Sponsored Link

Credit Rating (Bankruptcy Risk): DAIKEN MEDICAL (Annual ) Non-Consolidated

Date Credit Rating Comment Sales Current Profit Net Income
2013-03-31  BBB  Credit is enough, but be decreased potential by biz environs. ¥ 7 B
8.48%
¥ 1 B
23.27%
¥ 787 M
94.80%

Financial Timeline

Date  2012-12-31 
(Third quarter )
 2013-03-31 
(Annual )
 2013-06-30 
(First quarter )
 2013-09-30 
(Second quarter )
Credit Rating ABBBBBBBBB
Total Assets
¥ 7 B
¥ 7 B
¥ 7 B
¥ 7 B
Net Assets
¥ 4 B
¥ 5 B
¥ 4 B
¥ 5 B

Financial Statement Risk Analysis: DAIKEN MEDICAL (Annual ) (Non-Consolidated )

Special note
Net sales has increased 5 consecutive terms. The performance is good.
Net Assets have increased 5consecutive terms. The fiscal base is getting better.
[Date: 2013-03-31]  Danger : Warning : Caution : Good
Financing Good (*Operating Cash Flow is plus )
Investment Cash Flow (¥ -113 M) & Financial Cash Flow (¥ -843 M) is a minus, Operating Cash Flow (¥ 1 B) is a plus,
Dividend
Under the situation of Net Income (¥ 787 M) & Operating Cash Flow (¥ 1 B) , Dividend (¥ -170 M) is paid.
[Date: 2012-03-31]  Danger : Warning : Caution : Good
Management Risk (*Net Income is decrease )
Net Income (¥ 404 M) is first term Net Income (¥ 555 M) less , there is a possibility that the management situation has stagnated and deteriorated
Management Risk (*Net Profit Margin is decrease )
Net Profit Margin (6.20%) is first term Net Profit Margin (8.89%) less , there is a possibility that the profitability has deteriorated.
Dividend
Under the situation of Net Income (¥ 404 M) & Operating Cash Flow (¥ 254 M) , Dividend (¥ -162 M) is paid.
Financing Risk (*Operating Cash Flow is decrease )
Sales (¥ 6 B) is first term (¥ 6 B) more, however Operating Cash Flow (¥ 254 M) is first term (¥ 920 M) less , there is a possibility that the financing has deteriorated very much.
[Date: 2011-03-31]  Danger : Warning : Caution : Good
Financing Good (*Operating Cash Flow is plus )
Investment Cash Flow (¥ -246 M) & Financial Cash Flow (¥ -329 M) is a minus, Operating Cash Flow (¥ 920 M) is a plus,
Dividend
Under the situation of Net Income (¥ 555 M) & Operating Cash Flow (¥ 920 M) , Dividend (¥ -123 M) is paid.
[Date: 2010-03-31]  Danger : Warning : Caution : Good
Financing Good (*Operating Cash Flow is plus )
Investment Cash Flow (¥ -240 M) & Financial Cash Flow (¥ -318 M) is a minus, Operating Cash Flow (¥ 551 M) is a plus,
Dividend
Under the situation of Net Income (¥ 487 M) & Operating Cash Flow (¥ 551 M) , Dividend (¥ -79 M) is paid.
Financing Risk (*Operating Cash Flow is decrease )
Sales (¥ 5 B) is first term (¥ 5 B) more, however Operating Cash Flow (¥ 551 M) is first term (¥ 613 M) less , there is a possibility that the financing has deteriorated very much.
[Date: 2009-03-31]  Danger : Warning : Caution : Good
Financing Risk (*Issuance of new shares)
Financial Cash Flow (¥ -213 M) is a minus, Issuance of new shares (¥ 801 M) is plus. Because a possibility of having appropriated the capital-increase fund for repayment of borrowed money is high , there is a possibility that the financing is extremely severe.
Financing Good (*Operating Cash Flow is plus )
Investment Cash Flow (¥ -185 M) & Financial Cash Flow (¥ -213 M) is a minus, Operating Cash Flow (¥ 613 M) is a plus,
Dividend
Under the situation of Net Income (¥ 369 M) & Operating Cash Flow (¥ 613 M) , Dividend (¥ -48 M) is paid.

Related Information: DAIKEN MEDICAL (Annual )

Statement Type
Annual : DAIKEN MEDICAL
First quarter : DAIKEN MEDICAL
Second quarter : DAIKEN MEDICAL
Third quarter : DAIKEN MEDICAL
Analysis Menu
@Outline : DAIKEN MEDICAL
@Statement : DAIKEN MEDICAL
@Rating : DAIKEN MEDICAL
@Indicator : DAIKEN MEDICAL
@Download : DAIKEN MEDICAL
Industry Comparison Ranking
Precision Instruments - EDIUNET Industry Rankings
Precision Instruments - EDIUNET Credit Rating
Precision Instruments - EDIUNET Industry Avg
Comparison with a neighboring company
Osaka - EDIUNET Prefectures
Osaka大阪市 - EDIUNET Prefectures

Related company's newest statement

Date Company Credit Rating Date
1/15 シグマ光機 BBB 2013-11-30 (Q2)
1/15 RORZE B→BB 2013-11-30 (Q3)
1/9 スター精密 BB 2013-11-30 (Q3)
1/7 マニー AA 2013-11-30 (Q1)
12/13 インスペック C 2013-10-31 (Q2)
12/5 三井ハイテック A→AA 2013-10-31 (Q3)
12/5 アルチザネットワークス BB→BBB 2013-10-31 (Q1)
11/14 asahi intecc BBB→A 2013-09-30 (Q1)
11/14 黒田精工 B→CCC 2013-09-30 (Q2)
11/14 Precision Sysem Science CCC→BBB 2013-09-30 (Q1)

Ticker Market Industry Month report Rating
@ DAIKEN MEDICAL 7775 TSE 1st Precision Instruments 3 Annual BBB

Related Company

@ NAKANISHI (Sales ¥ 19 B)
@ Noritsu Koki (Sales ¥ 251 M)
@ ミツトヨ (Sales ¥ 65 B)
@ A-One Seimitsu (Sales ¥ 1 B)
@ フクダ電子 (Sales ¥ 59 B)
@ TAIYO KOKI CO,. (Sales ¥ 5 B)
@ TOKYO KEIKI (Sales ¥ 36 B)
@ Shimadzu (Sales ¥ 147 B)
@ Rigaku (Sales ¥ 24 B)
@ オリンパス (Sales ¥ 71 B)
@ Citizen Holdings (Sales ¥ 9 B)
@ HOGY MEDICAL  (Sales ¥ 32 B)
@ タムロン (Sales ¥ 57 B)
Sponsored Link


関連する株式投資情報

EDIUNET Caution

*Financial data might be different from the actual one. Please confirm the original, and read Caution.

*This site has obtained the information from the FSA's EDINET, Tokyo Stock Exchange's TDnet and Pay statistical data services, Fukuoka stock Exchange's Stock market capitalization, Center for Spatial Information Science's CSV Geocoding Service. The copyright of the information belongs to each corporation etc. .

▲ Go to the top ▲

  1. Guide
  2. Mobile
  3. Tablet
  4. Japanese
`EDIUNET` Copyright©2006-2024 `MAバンク` (0.069 sec.)